While both have important roles in weight management, they can work together to enhance your overall results
health care, noting that as of June 2023 there were 132 active shortages 58% of which were in shortage for over 2 years
To learn more about Calibrates transformative outcomes, access the full 2025 Results Report
Semaglutide at the 2.4 mg dose marketed as Wegovy is not currently listed on this formulary, though lower-dose semaglutide (Ozempic 0.5 mg, 1 mg, 2 mg) carries formulary status for type 2 diabetes management [1]
7 Clinical failures and translational limitations of PDE1B and PDE10A inhibitors in schizophrenia Given compelling preclinical data supporting PDE1B and PDE10A inhibition as therapeutic strategies for schizophrenia, the translation of these findings into clinical success has been significantly limited (Table 2)

When to Call Your Doctor Severe abdominal pain Significant bloating or abdominal swelling Persistent nausea or vomiting Inability to pass gas, which can sometimes be a sign of a blockage in the colon Blood in the stool Black or tarry stools, which may indicate bleeding higher in the digestive tract Pencil-thin stools, which can be a sign of a narrowing or blockage Unexplained weight loss beyond what would be expected from the medication Fever A sudden change in bowel habits A lack of bowel movement for three to seven days, despite making lifestyle changes or taking over-the-counter medications New or worsening constipation after previously doing well on a GLP-1 medication Symptoms that persist for more than a few weeks despite treatment Resources We Trust Cleveland Clinic: Could You Be Pooping Better